BIOS NAMED A LEADING TECHBIO COMPANY "DRIVING THE AI REVOLUTION" BY UK BIOINDUSTRY ASSOCIATION
Cambridge, UK – 24 October, 2023 - BIOS Health, a pioneer in the development of AI-driven precision medicine for decoding and treating the nervous system, has been named as a leading TechBio company by the UK BioIndustry Association.
The UK is emerging as a prominent global player in applying AI innovation to healthcare. A new UK Bioindustry Association (BIA) report highlights the increasing number of UK TechBio companies pioneering ground-breaking AI healthcare solutions, as well as the increasing volume of investment they are attracting. As the report notes: "Expansion and integration of patient data into early R&D decision-making will be transformational for the future of healthcare."
Five companies that are leading the way are highlighted in the report. These are:
This is the second time that BIOS Health has been recognised by the BIA, having previously been recognised in the BIA 2022 report.
About BIOS Health
BIOS is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals. The human nervous system carries vast quantities of data and scientists have long known that faulty signals in the nervous system play a key role in driving chronic diseases. By understanding and correcting these signals in real time, BIOS can treat chronic illnesses in an effective, automated, and personalised way. BIOS has leveraged recent breakthroughs in AI and Machine Learning to translate the “language” of the nervous system for the first time. BIOS’ neural code is built on the world’s largest proprietary neural data set and is already in use clinically to enhance data from wearables used in remote chronic disease care.
Co-founded by Cambridge University graduates Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer, BIOS is made up of a wide range of experts from neuroscience, machine learning, software engineering, applied biomaterials, biotechnology, and medicine. The combined experience of the BIOS team extends to over 300 peer-reviewed publications, 10+ First of kind medical devices and 6k+ clinical procedures.